Variant report
Variant | esv1824952 |
---|---|
Chromosome Location | chr3:159257120-159259458 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IQCJ-2 | chr3:159259268-159259491 | uc_130_+ |
2 | lnc-RP11-432B6.3.1-9 | chr3:159259268-159259491 | uc_130_- |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144625224 | chr3:159258241-159258242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549346440 | chr3:159258272-159258273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561004755 | chr3:159258277-159258278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs531372424 | chr3:159258313-159258314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs377454062 | chr3:159258319-159258320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1387693 | chr3:159258371-159258372 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs189468515 | chr3:159258397-159258398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs553095423 | chr3:159258418-159258419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs425269 | chr3:159258502-159258503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538355453 | chr3:159258556-159258557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192382957 | chr3:159258557-159258558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs566770281 | chr3:159258613-159258614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139380051 | chr3:159258655-159258656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144097877 | chr3:159258690-159258691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574264922 | chr3:159258728-159258729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538500404 | chr3:159258751-159258752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184689146 | chr3:159258757-159258758 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577773732 | chr3:159258780-159258781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545128734 | chr3:159258789-159258790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577932058 | chr3:159258794-159258795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13323265 | chr3:159258805-159258806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560567407 | chr3:159258819-159258820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140995644 | chr3:159258839-159258840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142136957 | chr3:159258843-159258844 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561103585 | chr3:159258952-159258953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540467010 | chr3:159258963-159258964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567290381 | chr3:159258968-159258969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79856692 | chr3:159258994-159258995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140111272 | chr3:159259003-159259004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113876718 | chr3:159259052-159259053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79061247 | chr3:159259114-159259115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs17799480 | chr3:159259124-159259125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565419909 | chr3:159259127-159259128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190224446 | chr3:159259147-159259148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113834919 | chr3:159259163-159259164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181366177 | chr3:159259193-159259194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2222328 | chr3:159259291-159259292 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundancedisease |
38 | rs567797653 | chr3:159259303-159259304 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs11720783 | chr3:159259315-159259316 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs556809525 | chr3:159259336-159259337 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs150290178 | chr3:159259345-159259346 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs368458034 | chr3:159259346-159259347 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs539014934 | chr3:159259393-159259394 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs554342593 | chr3:159259402-159259403 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs115585205 | chr3:159259406-159259407 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs1402276 | chr3:159259458-159259459 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21509527 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:159258200-159259400 | Enhancers | Fetal Brain Male | brain |